# ANDA Submissions - Refuse-to-Receive Standards: Questions and Answers Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/anda-submissions-refuse-to-receive-standards-questions-and-answers-guidance-for-industry/9263d6de-7354-4678-ba95-003ad712d3c3

> FDA guidance document: ANDA Submissions - Refuse-to-Receive Standards: Questions and Answers Guidance for Industry. Issue date: October 03, 2017. Get complete insights and analysis.

---

## Details

- Title: ANDA Submissions - Refuse-to-Receive Standards: Questions and Answers Guidance for Industry
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2017-10-03
- Comment Close Date: 2018-01-02
- Last Changed: 2020-04-21
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2017-D-5846">FDA-2017-D-5846</a>

## Related Documents

- [Establishing Impurity Specifications for Antibiotics](https://www.globalkeysolutions.net/guidances/guidance-document/establishing-impurity-specifications-for-antibiotics/5bb8badb-7c32-4b76-bfc9-bbb8ab55fb84)
- [Sameness Evaluations in an ANDA — Active Ingredients](https://www.globalkeysolutions.net/guidances/guidance-document/sameness-evaluations-in-an-anda-active-ingredients/56e63be0-f1f7-48cf-90e1-c9eb340486ef)
- [Physicochemical and Structural (Q3) Characterization of Topical Drug Products Submitted in ANDAs](https://www.globalkeysolutions.net/guidances/guidance-document/physicochemical-and-structural-q3-characterization-of-topical-drug-products-submitted-in-andas/791aaeaa-9e86-4bc4-8b71-477a833920f1)